238 related articles for article (PubMed ID: 7798679)
1. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.
Adler SP; Starr SE; Plotkin SA; Hempfling SH; Buis J; Manning ML; Best AM
J Infect Dis; 1995 Jan; 171(1):26-32. PubMed ID: 7798679
[TBL] [Abstract][Full Text] [Related]
2. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of the Towne strain cytomegalovirus vaccine.
Adler SP; Hempfling SH; Starr SE; Plotkin SA; Riddell S
Pediatr Infect Dis J; 1998 Mar; 17(3):200-6. PubMed ID: 9535246
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge.
Plotkin SA; Starr SE; Friedman HM; Gönczöl E; Weibel RE
J Infect Dis; 1989 May; 159(5):860-5. PubMed ID: 2540247
[TBL] [Abstract][Full Text] [Related]
5. A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.
Adler SP; Manganello AM; Lee R; McVoy MA; Nixon DE; Plotkin S; Mocarski E; Cox JH; Fast PE; Nesterenko PA; Murray SE; Hill AB; Kemble G
J Infect Dis; 2016 Nov; 214(9):1341-1348. PubMed ID: 27521362
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for the prevention of human cytomegalovirus infection.
Plotkin SA; Starr SE; Friedman HM; Gonczol E; Brayman K
Rev Infect Dis; 1990; 12 Suppl 7():S827-38. PubMed ID: 2173112
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
[TBL] [Abstract][Full Text] [Related]
9. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial.
Plotkin SA; Starr SE; Friedman HM; Brayman K; Harris S; Jackson S; Tustin NB; Grossman R; Dafoe D; Barker C
Ann Intern Med; 1991 Apr; 114(7):525-31. PubMed ID: 1848053
[TBL] [Abstract][Full Text] [Related]
10. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
Chiuppesi F; Wussow F; Johnson E; Bian C; Zhuo M; Rajakumar A; Barry PA; Britt WJ; Chakraborty R; Diamond DJ
J Virol; 2015 Dec; 89(23):11884-98. PubMed ID: 26378171
[TBL] [Abstract][Full Text] [Related]
11. The status of cytomegalovirus vaccine.
Starr SE; Friedman HM; Plotkin SA
Rev Infect Dis; 1991; 13 Suppl 11():S964-5. PubMed ID: 1664136
[TBL] [Abstract][Full Text] [Related]
12. A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.
Heineman TC; Schleiss M; Bernstein DI; Spaete RR; Yan L; Duke G; Prichard M; Wang Z; Yan Q; Sharp MA; Klein N; Arvin AM; Kemble G
J Infect Dis; 2006 May; 193(10):1350-60. PubMed ID: 16619181
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.
Gerna G; Lilleri D
New Microbiol; 2019 Jan; 42(1):1-20. PubMed ID: 30671581
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against the human cytomegalovirus.
Plotkin SA; Boppana SB
Vaccine; 2019 Nov; 37(50):7437-7442. PubMed ID: 29622379
[TBL] [Abstract][Full Text] [Related]
15. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
Wang Z; La Rosa C; Maas R; Ly H; Brewer J; Mekhoubad S; Daftarian P; Longmate J; Britt WJ; Diamond DJ
J Virol; 2004 Apr; 78(8):3965-76. PubMed ID: 15047812
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of pediatric nurses with live attenuated cytomegalovirus.
Fleisher GR; Starr SE; Friedman HM; Plotkin SA
Am J Dis Child; 1982 Apr; 136(4):294-6. PubMed ID: 6280490
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.
Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP
J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990
[TBL] [Abstract][Full Text] [Related]
18. Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.
Plachter B
Med Microbiol Immunol; 2016 Dec; 205(6):537-547. PubMed ID: 27519596
[TBL] [Abstract][Full Text] [Related]
19. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.
Fu TM; An Z; Wang D
Vaccine; 2014 May; 32(22):2525-33. PubMed ID: 24681264
[TBL] [Abstract][Full Text] [Related]
20. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z
J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
